Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies
Recruiting
N/A
Interventional Study
Urological Manifestations
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 214 (estimated)
- Sponsor
- Centre Hospitalier Intercommunal Robert Ballanger · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
any studies have shown the benefit of perioperative Oral Impact immunomodulation in gastrointestinal, ENT, gynecological and cardiac surgery. Studies in major Urological surgery are rare and not very contributory. The expected benefit is a reduction in postoperative complications and the average length of stay.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years of age and older
* Scheduled major urological surgery: scheduled: cystectomy, nephrectomy, other laparotomies.
* Having expressed their free and informed consent.
* Affiliated to a social security scheme
Exclusion Criteria:
* Immune deficiency.
* HIV infection.
…
Contacts